JP2023549455A5 - - Google Patents

Info

Publication number
JP2023549455A5
JP2023549455A5 JP2023524333A JP2023524333A JP2023549455A5 JP 2023549455 A5 JP2023549455 A5 JP 2023549455A5 JP 2023524333 A JP2023524333 A JP 2023524333A JP 2023524333 A JP2023524333 A JP 2023524333A JP 2023549455 A5 JP2023549455 A5 JP 2023549455A5
Authority
JP
Japan
Application number
JP2023524333A
Other languages
Japanese (ja)
Other versions
JP2023549455A (ja
JPWO2022093724A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/056517 external-priority patent/WO2022093724A1/en
Publication of JP2023549455A publication Critical patent/JP2023549455A/ja
Publication of JPWO2022093724A5 publication Critical patent/JPWO2022093724A5/ja
Publication of JP2023549455A5 publication Critical patent/JP2023549455A5/ja
Pending legal-status Critical Current

Links

JP2023524333A 2020-10-26 2021-10-25 脊髄性筋萎縮症を治療するための抗プロミオスタチン/抗潜在型ミオスタチン抗体の使用 Pending JP2023549455A (ja)

Applications Claiming Priority (19)

Application Number Priority Date Filing Date Title
US202063105850P 2020-10-26 2020-10-26
US63/105,850 2020-10-26
US202063106172P 2020-10-27 2020-10-27
US63/106,172 2020-10-27
US202163200955P 2021-04-05 2021-04-05
US63/200,955 2021-04-05
US202163201157P 2021-04-15 2021-04-15
US63/201,157 2021-04-15
US202163202317P 2021-06-06 2021-06-06
US63/202,317 2021-06-06
US202163202372P 2021-06-08 2021-06-08
US63/202,372 2021-06-08
US202163202900P 2021-06-29 2021-06-29
US63/202,900 2021-06-29
US202163260725P 2021-08-30 2021-08-30
US63/260,725 2021-08-30
US202163261398P 2021-09-20 2021-09-20
US63/261,398 2021-09-20
PCT/US2021/056517 WO2022093724A1 (en) 2020-10-26 2021-10-25 Use of anti-pro/latent myostatin antibody for treating spinal muscular atrophy

Publications (3)

Publication Number Publication Date
JP2023549455A JP2023549455A (ja) 2023-11-27
JPWO2022093724A5 JPWO2022093724A5 (https=) 2024-10-10
JP2023549455A5 true JP2023549455A5 (https=) 2024-10-10

Family

ID=78622120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023524333A Pending JP2023549455A (ja) 2020-10-26 2021-10-25 脊髄性筋萎縮症を治療するための抗プロミオスタチン/抗潜在型ミオスタチン抗体の使用

Country Status (13)

Country Link
US (1) US20240002490A1 (https=)
EP (2) EP4729069A1 (https=)
JP (1) JP2023549455A (https=)
KR (1) KR20230095998A (https=)
CN (1) CN116390756A (https=)
AU (1) AU2021369471A1 (https=)
CA (1) CA3193909A1 (https=)
ES (1) ES3058087T3 (https=)
IL (1) IL302132A (https=)
MX (1) MX2023004763A (https=)
PL (1) PL4232151T3 (https=)
TW (1) TW202233234A (https=)
WO (1) WO2022093724A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3350220T (lt) 2015-09-15 2021-09-27 Scholar Rock, Inc. Anti pro/latentinio miostatino antikūnai ir jų panaudojimas
DK4518970T3 (da) 2022-05-04 2026-04-07 Scholar Rock Inc Anvendelse af myostatinhæmmer til behandling af spinal muskelatrofi
IL321628A (en) 2022-12-22 2025-08-01 Scholar Rock Inc Selective and potent inhibitory antibodies for myostatin activation
WO2026076383A1 (en) 2024-10-06 2026-04-09 Scholar Rock, Inc. Use of myostatin inhibitor for treating spinal muscular atrophy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040044063A1 (en) 2002-05-31 2004-03-04 Brent Stockwell SMA therapy and cell based assay for identifying therapies
AU2008239606A1 (en) 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
LT3350220T (lt) 2015-09-15 2021-09-27 Scholar Rock, Inc. Anti pro/latentinio miostatino antikūnai ir jų panaudojimas
AU2017283546C1 (en) 2016-06-13 2020-11-19 Scholar Rock, Inc. Use of myostatin inhibitors and combination therapies

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2023549455A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR112023016292A2 (https=)
BR112023011539A2 (https=)
BR112023011610A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021015450A8 (https=)
BR102021015220A2 (https=)
BR102021015247A2 (https=)
BR102021014056A2 (https=)
BR102021014044A2 (https=)